Sickle Cell Disease: References

1. Strahan JE, Canfield MA, Drummond-Borg LM, Neill SU. Ethnic and gender patterns for the five congenital disorders in Texas from 1992 through 1998. Tex Med. 2002;98:80-86.

2. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5-11.

3. Grisham JE, Vichinsky EP. Ketorolac versus meperidine in vaso-occlusive crisis: A study of safety and efficacy. Int J Pediatr Hematol Oncol. 1996;3:239.

4. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW. Augmentation by erythropoietin of fetal hemoglobin response to hydroxyurea in sickle cell patients. N Engl J Med. 1993;328:73-80.

5. Gibbs WJ, Hagemann TM. Purified poloxamer 188 for sickle cell vaso-occlusive crisis. Ann Pharmacother. 2004;38:320-324.

6. Malinauskas BM, Gropper SS, Kawchak DA, et al. Impact of acute illness on nutritional status of infants and young children with sickle cell disease. J Am Diet Assoc. 2000;100:330-334.

7. Barden EM, Kawchak DA, Ohene-Frempong K, et al. Body composition in children with sickle cell disease. Am J Clin Nutr. 2002;76:218-225.

8. Williams R, Olivi S, Mackert P, et al. Comparison of energy prediction equations with measured resting energy expenditure in children with sickle cell anemia. J Am Diet Assoc. 2002;102:956-961.

9. Barden EM, Zemel BS, Kawchak DA, et al. Total and resting energy expenditure in children with sickle cell disease. J Pediatr. 2000;136:73-79.

10. Bergeron MF, Cannon JG, Hall EL, et al. Erythrocyte sickling during exercise and thermal stress. Clin J Sport Med. 2004;14:354-356.

11. Gray NT, Bartlett JM, Kolasa KM, et al. Nutritional status and dietary intake of children with sickle cell anemia. Am J Pediatr Hematol Oncol. 1992;14:57-61.

12. Tangney CC, Phillips G, Bell RA, et al. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA). Am J Hematol. 1989;32:161-166.

13. Segal JB, Miller ER III, Brereton NH, et al. Concentrations of B vitamins and homocysteine in children with sickle cell anemia. South Med J. 2004;97:149-155.

14. Westerman MP, Zhang Y, McConnell JP, et al. Ascorbate levels in red blood cells and urine in patients with sickle cell anemia. Am J Hematol. 2000;65:174-175.

15. Marwah SS, Blann AD, Rea C, et al. Reduced vitamin E antioxidant capacity in sickle cell disease is related to transfusion status but not to sickle crisis. Am J Hematol. 2002;69:144-146.

16. Zehtabchi S, Sinert R, Rinnert S, et al. Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients with sickle cell anemia. Am J Hematol. 2004;77:215-222.

17. Zemel BS, Kawchak DA, Fung EB, et al. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr. 2002;75:300-307.

18. Riddington C, De Franceschi L. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2002;CD003426.

19. Blann AD, Marwah S, Serjeant G, et al. Platelet activation and endothelial cell dysfunction in sickle cell disease is unrelated to reduced antioxidant capacity. Blood Coagul Fibrinolysis. 2003;14:255-259.

20. Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2001;2:280-285.

21. Jaja SI, Ikotun AR, Gbenebitse S, et al. Blood pressure, hematologic and erythrocyte fragility changes in children suffering from sickle cell anemia following ascorbic acid supplementation. J Trop Pediatr. 2002;48:366-370.

22. Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: a potential nutritional approach for a molecular disease. Nutrition. 2000;16:330-338.

23. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest. 1997;100:1847-1852.

24. Muskiet FA, Muskiet FD, Meiborg G, et al. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil. Am J Clin Nutr. 1991;54:736-744.

25. Glew RH, Casados JK, Huang YS, et al. The fatty acid composition of the serum phospholipids of children with sickle cell disease in Nigeria. Prostaglandins Leukot Essent Fatty Acids. 2002;67:217-222.

26. VanderJagt DJ, Trujillo MR, Bode-Thomas F, Huang YS, Chuang LT, Glew RH. Phase angle and n-3 polyunsaturated fatty acids in sickle cell disease. Arch Dis Child. 2002;87:252-254.

27. Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost. 2001;85:966-974.

28. Ballas SK, Smith ED. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood. 1992;79:2154-2163.